SINOVAC BIOTECH LTD Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
SINOVAC BIOTECH LTD (SVA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2023-12-31, per its 20-F filed 2024-04-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2024-04-29
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|
| 2023-12-31 | $0.00 20-F · filed 2024-04-29 |
| 2018-12-31 | $2.37 20-F · filed 2019-04-29 |
| 2016-12-31 | $0.00 20-F · filed 2017-11-22 |
| 2015-12-31 | $4.98 20-F · filed 2016-04-25 |